CAPR Deadline Alert: SueWallSt Reminds Capricor Therapeutics, Inc. (CAPR) Investors of Securities Class Action Deadline on September 28, 2026
Levi & Korsinsky, via its SueWallSt brand, is soliciting lead plaintiffs for a securities class action filed against Capricor Therapeutics (NASDAQ: CAPR) on behalf of purchasers between December 17, 2025 and July 26, 2026, with motions due September 28, 2026. The stock fell approximately 78.7%, from $19.70 on July 24, 2026 to $4.19, after the July 27 release of FDA briefing documents and a 9-3 advisory committee vote against efficacy support.
Key figures
- Court
- U.S. District Court for the Southern District of California
- Adcom vote
- 9-3 against efficacy support
- Class period
- December 17, 2025 to July 26, 2026
- Per share loss
- $15.08
- Trial patients
- 106
- Pdufa target date
- August 22, 2026
- Stock decline pct
- 78.7%
- Stock price after
- 4.19
- Stock price prior
- 19.7
- Lead plaintiff deadline
- September 28, 2026
- Hypersensitivity placebo pct
- 15%
- Hypersensitivity treated pct
- 42%
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.